Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review
Platinum (Pt) derivatives such as cisplatin and carboplatin are the class of drugs with proven activity against triple-negative breast cancer (TNBC). This is due to the ability of Pt compounds to interfere with the DNA repair mechanisms of the neoplastic cells. Taxanes have been efficacious against...
Saved in:
Main Authors: | Hao Tian (Author), Dandan Ma (Author), Xuanni Tan (Author), Wenting Yan (Author), Xiujuan Wu (Author), Cheng He (Author), Ling Zhong (Author), Yan Zhang (Author), Bingjie Yu (Author), Yi Zhang (Author), Xiaowei Qi (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Taxanes in adjuvant and neoadjuvant therapy for breast cancer
by: S. V. Limareva
Published: (2014) -
Neoadjuvant chemotherapy outcome with taxane-based versus non-taxane protocols in gastric cancer
by: Shirin Kianersi, et al.
Published: (2023) -
Real-world data on adjuvant capecitabine after standard neoadjuvant chemotherapy for triple negative breast cancer
by: Maria Fernanda Imperio Pereira, et al.
Published: (2024) -
The role of carboplatin in the neoadjuvant chemotherapy treatment of triple negative breast cancer
by: Aurelio Bartolome Castrellon, et al.
Published: (2017) -
The role of taxanes in triple-negative breast cancer: literature review
by: Mustacchi G, et al.
Published: (2015)